Schroder Investment Management Group
VIR icon

Schroder Investment Management Group’s Vir Biotechnology VIR Stock Holding History

Schroder Investment Management Group’s Portfolio VIR Stock Details VIR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-598,673
Closed -$3.5M – 1261
2025
Q4 		$3.5M Buy
598,673
+142,381
+31% +$848K ﹤0.01% 811
2025
Q3 		$2.57M Sell
456,292
-384,141
-46% -$1.96M ﹤0.01% 883
2025
Q2 		$4.24M Hold
840,433
– – ﹤0.01% 796
2025
Q1 		$5.63M Buy
+840,433
New +$7.47M 0.01% 739
2024
Q1 		– Sell
-47,000
Closed -$473K – 1248
2023
Q4 		$473K Buy
+47,000
New +$429K ﹤0.01% 1095
2023
Q3 		– Sell
-25,940
Closed -$636K – 1247
2023
Q2 		$636K Hold
25,940
– – ﹤0.01% 1097
2023
Q1 		$604K Sell
25,940
-8,592
-25% -$220K ﹤0.01% 1118
2022
Q4 		$874K Buy
34,532
+14,831
+75% +$364K ﹤0.01% 1066
2022
Q3 		$380K Buy
+19,701
New +$501K ﹤0.01% 1176

Other funds holding VIR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AVM
Arch Venture Management Chicago, Illinois $1.1B AUM 356.62% 1-Year Est. Return
SIAU
SB Investment Advisers (UK) London, United Kingdom $7.66B AUM 20.12% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
GP
GSK plc London $602M AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return

Schroder Investment Management Group's VIR Position: Q1 2026 in Review

Schroder Investment Management Group sold out of Vir Biotechnology (VIR) in Q1 2026, closing a stake of 598,673 shares — an estimated $3.5M sold.

Schroder Investment Management Group first reported a position in VIR in Q3 2022 and held it in 9 quarters. The position peaked at $5.63M in Q1 2025. 252 funds tracked by Wall St. Rank hold VIR as of Q1 2026.

  • Schroder Investment Management Group reported no remaining Vir Biotechnology position as of Q1 2026 after selling out during the quarter.
  • Schroder Investment Management Group sold 598,673 Vir Biotechnology shares in Q1 2026, an estimated $3.5M.
  • Schroder Investment Management Group first reported a position in Vir Biotechnology in Q3 2022 and held it in 9 quarters.
  • Schroder Investment Management Group's Vir Biotechnology position peaked at $5.63M in Q1 2025.
  • 252 funds tracked by Wall St. Rank held Vir Biotechnology as of Q1 2026.

Based on Schroder Investment Management Group's 13F filing for Q1 2026, filed 14 May 2026.